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MOZART’SREQUIEM--LIVERTRANSPLANTATION
IN 1988
J. M. LITTLE
Professor ofSurgery, Department ofSurgery, Westmead Hospital, Westmead
(Receioed 10 April 1989)
Liver transplantation is one of the most spectacular of surgical achievements. It is a demanding and
expensive procedure, requiring great surgical skill and a great depth ofsupporting services. Precisely because
it is a procedure at the leading edge ofmedicine, more and more units in developed countries are pressing to
be allowed to carry it out. But there are many moral and ethical problems, some of which can be usefully
examined using a "Mozart model" as proposed by Starzl.
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I had the privilege of attending a meeting of a surgical society devoted to the study of
diseases ofthe liver, biliary tree and pancreas in Bologna during the autumn of 1988
a privilege partly because it was one of the meetings held to celebrate the nine
hundredth anniversary of the University of Bologna. It was a good meeting which
focused much of its scientific attention on the medical problems of liver
transplantation. Indeed, one ofits central purposes was to honourDrThomas Starzl of
Pittsburgh for his astonishing achievements as a pioneer ofliver transplantation. Some
of the Italian speakers also reported their small and early experiences, while Bismuth
from Paris, Broelsch from Chicago and Otte from Louvain in Belgium reported the
experience of busy and well established units in other countries.
This was stirring material indeed. All the speakers emphasized that the operation
saves lives and can produce good quality oflife in the survivors. Furthermore, the study
of the biology and immunology of liver transplantation can produce new insights into
the function of the liver in health and disease. The success of liver transplantation can
produce new insights into the function ofthe liver in health and disease. The success of
liver transplantation had, moreover, had significant social impact. It was dramatic and
demanding of resources. If transplantation was not available, the patient was usually
doomed since there is no hepatic equivalent ofa dialysis machine which will artificially
duplicate the multitudinous functions of the liver. For these reasons, more countries
had confronted the problem of defining brain death to allow optimal conditions for
harvesting the liver; and more countries were coming to terms with the concept of self-
recycling, allowing such measures as endorsement of the driving licences of potential
donors. Unfortunately, for various financial, religious and social reasons, these
benefits and changes had not evolved in China, Africa, India nor the Islamic countries.
While the developments were striking and remarkable, they were available to a good
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deal less than halfthe world’s population. Despite this, liver transplantation has done
much to nurture international exchange. Students from many countries were spending
time at the established transplant units, and organs were being sent across national
boundaries.
Starzl addressed delegates twice- once in a formal lecture, once on receiving the
honorary Laurea of the University of Bologna. He has some interesting and striking
messages. He pointed to the high success rate now achieved by liver transplantation,
with 70% ofa population with no other future alive at one year. He felt some doubts
about the propriety oftransplanting patients with active hepatitis B virus infection and
those with most malignant tumours of the liver. Neither of these groups did well,
because the diseases which prompted the transplant recurred either in the new liver or
elsewhere in the body. On the other hand, he had found that alcoholics had fared
remarkably well, and he thought that reform from drinking was made easier by the
very drama and stress ofthe operation. It is certainly remarkable to hear that a group
of alcoholics have reformed so completely. Experience of other conditions, such as
bleeding varices and chronic pancreatitis, is much less favourable.
Starzl also pointed out that liver transplantation has allowed some biological access
to problems such as hypercholesterolaemia, and that experience ofa single case could
shed more light than years ofwork in a laboratory. In short, he saw transplantation
generally and liver transplantation in particular as one ofthe keys tomodem medicine
and its relationship to society. He asked his audience at the presentation of his
honorary Laurea to consider the history ofmusic iftransplantation had been available
for Wolfgang Amadeus Mozart. To have added years to Mozart’s life might have
added music ofsublime quality. Mozart’s contemporary musical influence might have
spread. The history ofmusic might have been very different.
Amidst this euphoria, there was one small discord. Otte, talking of liver
transplantation in children, warned his audience that the cost ofproviding a paediatric
transplant service for European countries outside Belgium was becoming too great in
Louvain, and that some limits would need to be set. This warning was directed
particularly to his Italian hosts, who supplied most of the children ofwhom Otte was
speaking. To an outsider, this was a puzzling reference to cost, which was not
mentioned elsewhere in the lectures and presentations.
At the lunch table, however, there was a different agenda. There was concern about
the availability oflivers, and concern about the regulation ofaccess to available organs.
Methods of supply and demand are regulated largely by finance. At one centre in the
U.S.A., the asking price for a liver transplant is $170,000, at another $135,000. State
funding for the programme in Louvain can barely cope with the needs ofchildren from
other countries. In Italy, state funding has meant the imposition ofquotas for each of
the funded transplant units. One major service, for example, is allowed to do only 20
transplants each year.
Some remained doubtful about the advisability of transplantation in alcoholics,
feeling that patient selectionwas all important. An alcoholicwith enoughmoney to pay
for a transplant is likely to be better motivated than one who lives on a state pension.
Most were anxious that Starzl’s message could be taken too literally, without a careful
analysis of the type of alcoholic being seen in each country by the units performing
transplant surgery.
But most concern was shown over the nexus between finance and the availability of
the operation. It is worthwhile to examine this issue further. There seem to be four
socio-economic models to be considered-- the free-market, the fully regulated, the
mixed and the open systems.LIVER TRANSPLANTATION 17
Under the free-market system- as seen to some degree in the United States the
user pays, and if the user cannot pay he or she does not have a liver transplant. The
justifications of this system are easily made. By hiving off this expense to the private
sector, the government is not directly involved and does not perceive the high cost as a
major threat to its health budget. At least some people have access to a method of
treatment that saves lives. The economically successful and their families deserve this
access. The problems are just as easily identified. The personal cost is enormous. Ifthe
cost of the operation is to be covered by insurance schemes, insurance premiums will
rise, the more so as the number of operations rises. The wealthy benefit not only from
exclusive availability of the operation. Liver transplantation uses resources, including
large amounts ofblood, which are not then readily available to charity patients. Nor is
it fair to say that only the rich deserve the operation. There are worthwhile members of
the poor. Mozart was one ofthem. Finally, ifthe wealthy are the only group to benefit,
decisions that should be made on medical grounds will be made for economic reasons.
Is the fully regulated system as seen in Italy a better one? In this model,
government funds the programmes, and at least in theory- the operation is
available to all for medical, not economic indications. But since government supplies
the funds, the budget is controlled by government which must also find money for
other areas of health, defence, education, the arts and roads. Such a system demands
careful definition of guidelines for the inclusion and exclusion of patients with liver
disease. There does not seem to have been a concerted attempt to define these criteria,
and indeed it .may not be possible to develop anything more than the broadest
guidelines. Ifa limit of20 cases in each year is imposed on a particular unit as it is for
one Italian unit, then a few emergency transplants will completely destroy a
carefully planned waiting list. In France, the audience was told by Bismuth, a donor
liver will be available within 24 hours when an emergency is notified to the national
transplant agency. In other countries, availability is less certain. What is certain is the
confusion caused by the insertion of an emergency case at the top of the planned
waiting list.
The mixed system allows a government regulated stream to run alongside a privately
funded stream. This may seem at first to be more equitable, but it is unlikely to be so.
Government, perceiving that private enterprise is taking a share of the financial
burden, is likely to reduce the funding for the public sector. One country will therefore
have an ’open’ stream for the wealthy and a ’restricted’ sector for the poor.. Equity is
unlikely to flourish for long.
A completely open system is one in which all citizens have equal access to
transplantation. Inclusion in the programme and priority on the list are determined by
medical need alone. The expense is a national one, to be met from taxes and insurance
premiums. While this may be seen to be an ideal system, it may only be possible in
egalitarian countries like Sweden and Australia. Further, it may only be possible in
countries with small populations, since a large population will generate such a pressure
of numbers that the starting budget will soon blow out, with a predictable response
from government. It will obviously be possible only in countries that are relatively
wealthy and that have at least some leaning toward a welfare state. It is also likely that
programmes of this kind will develop in countries that are relatively unimportant in
world politics. In the more important, the defence budget will compete too much.
Sadly, the very success ofsuch a system willcontain the seeds ofits own destruction. As
its reputation grow, the pressure on its facilities will increase. As more personnel are
hired and more equipment bought, costs will spiral. Eventually government will
intervene, and an open system will be converted into a fully regulated one.18 J.M. LITTLE
It is interesting to consider the fate of Mozart as a potential transplant recipient
under these different systems. But first it is necessary to digress a little and to consider
the nature of Mozart’s earlier health and his final illness’. Despite his abundant
vitality, Mozart’s health was never robust. As a child, he probably suffered from
recurrent streptococcal infections, with erythema nodosum, rheumatic fever, Henoch-
Schonlein purpura and perhaps glomerulonephritis. He also endured typhoid,
smallpox, dental abscesses, frostbite, recurrent bronchitis and an episode ofjaundice
(presumably caused by hepatitis A virus).
His final illness was called "acute military fever" on his death certificate, but this
non-specific diagnosis, referring to fever and skin rash, does not help us much. We
know from contemporary accounts that for some weeks before his death Mozart had
been unwell and depressed. He had suffered from several blackouts and he complained
of joint pains. He developed generalised oedema, fevers and vomiting. His son
mentioned a terrible smell that filled the sick room. The presence of a rash can be
inferred from the diagnosis of acute military fever. Two hours before death, Mozart
suffered from convulsions, became unconscious and was noted to turn his head to one
side and to breathe with his cheeks puffing out.
Dr P.J. Davies has postulated that Mozart suffered from longstanding immune
complex disease caused by recurrent streptococcal infection. He probably suffered
from chronic renal failure for some years. His final illness was perhaps precipitated by a
further bout ofstreptococcal infection contracted at a Masonic Lodge meeting on 18th
November, 1791. There is evidence that many people contracted a similar infection
during a particularly severe winter in Vienna. The immune complex disease that
followed caused acute renal failure with hypertension and Henoch-Schonlein purpura.
The uncontrolled hypertension and low platelet count ultimately produced a cerebral
haemorrhage.
This line of speculation may or may not be correct. Starzl’s point was that a
transplant presumably renal might have saved Mozart’s life. So, he could have
added, might better hygiene, control of hypertension, antibiotics, steroids and renal
dialysis. The possibilities are so many that the exercise becomes almost pointless. But
there is some point in considering Mozart as a potential transplant candidate,
particularly ifwe extend the fantasy and assume that he needed a liver transplant. Liver
transplantation is more expensive and less readily available than renal transplantation.
Let us first look at his background. He was loved by many musicians like Haydn
and J.C. Bach and by many of his contemporaries. But he was not particularly
favoured by those in power, amongst whom he had influential acquaintances but few
friends. He had suffered innumerable rebuffs and slights from the wealthy and
powerful in Salzburg, Mannheim, Munich, Prague and Paris. Only during his terminal
illness was he granted his first tenured post as kapellmeister at St Stephen’s Cathedral
in Vienna. Until then, he had relied on commissions and the sale ofhis works. He was,
at the time of his death, desperately poor. The equivalent of about $200 in
contemporary terms was found about the house. An inventory of his effects revealed
possessions to the value of about $2000. His debts totalled about $3000. Over the
preceding few years, he had repeatedly borrowed from his brother Masons. Prosperity
might have been around the corner, but it had not arrived.
Under which system would Mozart have got his hypothetical liver transplant7
Under the open market system? He certainly could not have afforded it personally.
Wealthy sponsors were not in evidence, having shown little tendency to help before his
death. Under a private system, a transplant would have cost about 50,000 gulden ofLIVER TRANSPLANTATION 19
1791, which would have been a lot for the Masons to find, particularly as the Masons
were being restricted in their activities and freedoms by Leopold II in Vienna. In the
fully regulated and mixed systems, Mozart would enter the hepatic transplantation list
for the poor on medical grounds, and no one could be too sure how his history of
repeated previous infections would have affected his chances ofinclusion on the list. If
he was entered during his final, fulminant illness (all over in about 2 weeks), he might
have got his transplant in France, but presumably only ifhe were a French national. If
he were to be transplanted during the chronic phase, he would have had to wait his turn
in his own country, and wait for a suitable donor. Ifa "quota" oftransplants had been
done for the year, he might not have been transplanted at all. Only under an open
system could he have been guaranteed equitable access to the transplant list.
Even this brief and incomplete analysis of the "Mozart problem" shows how
dangerous it is to use historical analogies out of all context. The unknowns are too
many, the certainties too few, and this without even touching on the possible effects
of immune suppressive regimes on creativity. But the examination of the case of
Mozart has been useful in clarifying some of the ethical issues, which must persist even
in the most starry-eyed view ofhepatic transplantation. It is not available to the bulk of
the world’s population in China, India and Africa, countries in which liver disease is
particularly common. It is most available where wealth is most available. Details ofthe
costs and benefits under the different schemes ofhealth care delivery are not clear. And
no one seems keen to investigate the numbers at risk globally and to determine what
facilities should be made available worldwide. Nor does anyone seem keen to confront
the issues ofwealth as the first pre-requisite in a free market system, of arbitrary limits
in the regulated and mixed systems and of the eventual self-destruction of the open
system.
There is, in short, a need to think through some of the issues that surround liver
transplantation. First, the profession must examine its attitude to concentrating
expertise. Liver transplantation is so demanding of technical expertise and resources,
both human and physical, that its performance must be confined to a few units only.
The trouble is that once a procedure is deemed to be at the cutting edge of medical
endeavour, more and more units feel it necessary to provide that procedure. We saw
how destructive that could be to cardiac surgery in the last generation. The profession
will have to confront this issue now. Hepatic transplantation is too expensive to be
allowed to proliferate in the traditional way until each city has 8 units performing 20
transplants each year, instead ofone major unit performing 160, with concentration of
expertise and economy of scale.
Second, though no less important, the profession and the politicians must determine
a way to make hepatic transplantation equally available to the rich and the poor. This
statement has nothing to do with personal political views. It is a statement ofbeliefin a
fundamental human fight. Even the most rabid free-marketeer will agree that some are
poor because of illness. They must have the right to be made whole. (This applies only
to developed countries. It does not even touch on the moral dilemma that liver
transplantation raises by widening the gap between the developed and undeveloped
countries.)
Third, each society must determine what proportion of national wealth can be set
aside for hepatic transplantation. On this decision will turn the size of quotas in the
regulated system, to which I suspect all systems will converge in time.
Fourth, the profession mustwork hard and honestly to define the indications for and
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viral persistence, oftumour recurrence must all be studied and reviewed but not by
everyone at once. We do not have models of all these things which can be readily taken
to the laboratory. Our only model is the illness of man. Let each unit try to solve the
problems that most beset them and that they are best equipped to solve. If all the
transplant units try to solve the problem of transplantation for hepatitis B infection,
many wasted transplants will be performed. If one or two units push forward such
experimental work with virologists who have new therapies available, then we may
have progress with the greatest economy ofhuman life and medical resources. Above
all things, the transplanters must communicate with one another. They are working
with a most expensive and precious experimental model. Their work must be co-
ordinated. They will need to be more generous to one another than is usual among the
medical profession.
There are many other issues to be confronted at both national and international
gatherings. They include the balance between coercive law and national choice that
must be made by each community, and the effects that such decisions may have on the
international exchange of donor organs. Will a country that introduces some laws to
procure more donor organs feel obliged to send organs to other countries that leave
organ donation to the choice of its people? And what should be done about those
countries that feel religious, moral or social reluctance to donate, although perhaps no
such reluctance to receive?
Ultimately, Starzl is right to see liver transplantation as a key to modern society. It is
unfortunately also a key to a Pandora’s box. In that box are issues that will test the
sincerity ofboth governments and the medical profession. They will test to the limit a
government’s real commitment to individual health; and they will equally test to the
limit the profession’s ability to concede and concentrate expertise.
We could do worse than to propose a simple test for clinicians and administrators to
apply to their established or proposed hepatic transplant units. It might be called The
Mozart Test. It consists in answering honestly the question "Is this unit available for
certain to provide a transplant for a sick, impoverished, powerless man, who may or
may not be a genius?" Ifthe answer is "Yes", then the unit will have fulfilled at least its
first obligation.
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